ReviewJournal of bone oncology2019

Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials.

Antonio Galvano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.